Skip to main content

MEJORA DEL RENDIMIENTO DIAGNOSTICO EN GENES SARCOMERICOS DE GRAN TAMAÑO

AC19/00048

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Programación Conjunta Internacional
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Execution centre HOSPITAL VALLE DE HEBRON

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Inferring disease course from differential exon usage in the wide titinopathy spectrum

  • Di Feo, Maria Francesca|||0000-0002-4090-9521
  • Oghabian, Ali
  • Nippala, Ella
  • Gautel, Mathias
  • Jungbluth, Heinz
  • Forzano, Francesca
  • Malfatti, Edoardo|||0000-0001-7871-8600
  • Castiglioni, Claudia
  • Krey, Ilona
  • Gómez-Andrés, David|||0000-0001-5654-7791
  • Brady, Angela F.
  • Iascone, Maria
  • Cereda, Anna
  • Pezzani, Lidia
  • Natera-de Benito, Daniel|||0000-0001-7764-2085
  • Nascimiento Osorio, Andrés
  • Estévez-Arias, Berta|||0000-0002-1711-7489
  • Kurbatov, Sergei A.
  • Attie-Bitach, Tania
  • Nampoothiri, Sheela
  • Ryan, Erin
  • Morrow, Michelle M.|||0000-0001-9475-0934
  • Gorokhova, Svetlana|||0000-0001-6870-4061
  • Chabrol, Brigitte
  • Sinisalo, Juha
  • Tolppanen, Heli|||0000-0002-3364-8554
  • Tolva, Johanna
  • Munell Casadesus, Francina|||0000-0001-8580-2819
  • Camacho, Jessica|||0000-0001-8018-8274
  • Sánchez Durán, María Ángeles|||0000-0001-9767-2564
  • Johari, Mridul|||0000-0002-3549-558X
  • Tajsharghi, Homa|||0000-0001-8854-5213
  • Hackman, Peter
  • Udd, Bjarne
  • Savarese, Marco|||0000-0002-2591-244X
Biallelic titin truncating variants (TTNtv) have been associated with a wide phenotypic spectrum, ranging from complex prenatal muscle diseases with dysmorphic features to adult-onset limb-girdle muscular dystrophy, with or without cardiac involvement. Given the size and complexity of TTN, reaching an unequivocal molecular diagnosis and precise disease prognosis remains challenging. In this case series, 12 unpublished cases and one already published case with biallelic TTNtv were collected from multiple international medical centers between November 2022 and September 2023. TTN mutations were detected through exome or genome sequencing. Information about familial and personal clinical history was collected in a standardized form. RNA-sequencing and analysis of TTN exon usage were performed on an internal sample cohort including postnatal skeletal muscles, fetal skeletal muscles, postnatal heart muscles, and fetal heart muscles. In addition, publicly available RNA-sequencing data was retrieved from ENCODE. We generated new RNA-seq data on TTN exons and identified genotype-phenotype correlations with prognostic implications for each titinopathy patient (whether worsening or improving in prenatal and postnatal life) using percentage spliced in (PSI) data for the involved exons. Interestingly, thanks to exon usage, we were also able to rule out a titinopathy diagnosis in one prenatal case. This study demonstrates that exon usage provides valuable insights for a more exhaustive clinical interpretation of TTNtv; additionally, it may serve as a model for implementing personalized medicine in many other genetic diseases, since most genes undergo alternative splicing.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

OBSCN undergoes extensive alternative splicing during human cardiac and skeletal muscle development

  • Oghabian, Ali
  • Jonson, Per Harald
  • Gayathri, Swethaa Natraj
  • Johari, Mridul
  • Nippala, Ella
  • Camacho, Jessica
  • Sinisalo, Juha
  • Gómez-Andrés, David
  • Munell Casadesus, Francina
  • Sanchez-Duran, M Angeles
Exon inclusion; Muscle development; Neuromuscular diseases, Inclusión de exones; Desarrollo muscular; Enfermedades neuromusculares, Inclusió d'exons; Desenvolupament muscular; Malalties neuromusculars, Background Highly expressed in skeletal muscles, the gene Obscurin (i.e. OBSCN) has 121 non-overlapping exons and codes for some of the largest known mRNAs in the human genome. Furthermore, it plays an essential role in muscle development and function. Mutations in OBSCN are associated with several hypertrophic cardiomyopathies and muscular disorders. OBSCN undergoes extensive and complex alternative splicing, which is the main reason that its splicing regulation associated with skeletal and cardiac muscle development has not previously been thoroughly studied. Methods We analyzed RNA-Seq data from skeletal and cardiac muscles extracted from 44 postnatal individuals and six fetuses. We applied the intron/exon level splicing analysis software IntEREst to study the splicing of OBSCN in the studied samples. The differential splicing analysis was adjusted for batch effects. Our comparisons revealed the splicing variations in OBSCN between the human skeletal and cardiac muscle, as well as between post-natal muscle (skeletal and cardiac) and the pre-natal equivalent muscle. Results We detected several splicing regulations located in the 5’end, 3’ end, and the middle of OBSCN that are associated with human cardiac or skeletal muscle development. Many of these alternative splicing events have not previously been reported. Our results also suggest that many of these muscle-development associated splicing events may be regulated by BUB3. Conclusions We conclude that the splicing of OBSCN is extensively regulated during the human skeletal/cardiac muscle development. We developed an interactive visualization tool that can be used by clinicians and researchers to study the inclusion of specific OBSCN exons in pre- and postnatal cardiac and skeletal muscles and access the statistics for the differential inclusion of the exons across the studied sample groups. The OBSCN exon inclusion map related to the human cardiac and skeletal muscle development is available at http://psivis.it.helsinki.fi:3838/OBSCN_PSIVIS/. These findings are essential for an accurate pre- and postnatal clinical interpretation of the OBSCN exonic variants., Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital). We would like to acknowledge that our research was supported by Magnus Ehrnrooth foundation (AO), Samfundet Folkhälsan i Svenska Finland (MS, BU), Jane and Aatos Erkko foundation (PH), Academy of Finland (MS, BU), European Joint Program on Rare Diseases (BU, FM), Sydäntutkimussäätiö (MS), CoMPaSS-NMD (funded by the European Union under Grant Agreement n° 101080874) and Instituto de Salud Carlos III, Spain (project number AC19/00048 to FM). Open access was funded by Helsinki University Library.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

OBSCN undergoes extensive alternative splicing during human cardiac and skeletal muscle development

  • Oghabian, Ali
  • Jonson, Per Harald
  • Gayathri, Swethaa Natraj
  • Johari, Mridul
  • Nippala, Ella
  • Camacho, Jessica
  • Sinisalo, Juha
  • Gómez-Andrés, David
  • Munell Casadesus, Francina
  • Sanchez-Duran, M Angeles
Exon inclusion; Muscle development; Neuromuscular diseases, Inclusión de exones; Desarrollo muscular; Enfermedades neuromusculares, Inclusió d'exons; Desenvolupament muscular; Malalties neuromusculars, Background Highly expressed in skeletal muscles, the gene Obscurin (i.e. OBSCN) has 121 non-overlapping exons and codes for some of the largest known mRNAs in the human genome. Furthermore, it plays an essential role in muscle development and function. Mutations in OBSCN are associated with several hypertrophic cardiomyopathies and muscular disorders. OBSCN undergoes extensive and complex alternative splicing, which is the main reason that its splicing regulation associated with skeletal and cardiac muscle development has not previously been thoroughly studied. Methods We analyzed RNA-Seq data from skeletal and cardiac muscles extracted from 44 postnatal individuals and six fetuses. We applied the intron/exon level splicing analysis software IntEREst to study the splicing of OBSCN in the studied samples. The differential splicing analysis was adjusted for batch effects. Our comparisons revealed the splicing variations in OBSCN between the human skeletal and cardiac muscle, as well as between post-natal muscle (skeletal and cardiac) and the pre-natal equivalent muscle. Results We detected several splicing regulations located in the 5’end, 3’ end, and the middle of OBSCN that are associated with human cardiac or skeletal muscle development. Many of these alternative splicing events have not previously been reported. Our results also suggest that many of these muscle-development associated splicing events may be regulated by BUB3. Conclusions We conclude that the splicing of OBSCN is extensively regulated during the human skeletal/cardiac muscle development. We developed an interactive visualization tool that can be used by clinicians and researchers to study the inclusion of specific OBSCN exons in pre- and postnatal cardiac and skeletal muscles and access the statistics for the differential inclusion of the exons across the studied sample groups. The OBSCN exon inclusion map related to the human cardiac and skeletal muscle development is available at http://psivis.it.helsinki.fi:3838/OBSCN_PSIVIS/. These findings are essential for an accurate pre- and postnatal clinical interpretation of the OBSCN exonic variants., Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital). We would like to acknowledge that our research was supported by Magnus Ehrnrooth foundation (AO), Samfundet Folkhälsan i Svenska Finland (MS, BU), Jane and Aatos Erkko foundation (PH), Academy of Finland (MS, BU), European Joint Program on Rare Diseases (BU, FM), Sydäntutkimussäätiö (MS), CoMPaSS-NMD (funded by the European Union under Grant Agreement n° 101080874) and Instituto de Salud Carlos III, Spain (project number AC19/00048 to FM). Open access was funded by Helsinki University Library.